NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,650 | +21.9% | 134 | +20.7% | 0.00% | +50.0% |
Q2 2023 | $11,202 | +20.6% | 111 | +9.9% | 0.00% | 0.0% |
Q1 2023 | $9,292 | +169.6% | 101 | +165.8% | 0.00% | +100.0% |
Q4 2022 | $3,447 | -31.1% | 38 | -39.7% | 0.00% | -50.0% |
Q3 2022 | $5,000 | 0.0% | 63 | +12.5% | 0.00% | 0.0% |
Q2 2022 | $5,000 | +66.7% | 56 | +51.4% | 0.00% | +100.0% |
Q4 2021 | $3,000 | 0.0% | 37 | -9.8% | 0.00% | 0.0% |
Q3 2021 | $3,000 | – | 41 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |